381 related articles for article (PubMed ID: 34052294)
1. Evaluating mismatch repair deficiency for solid tumor immunotherapy eligibility: immunohistochemistry versus microsatellite molecular testing.
Saeed OAM; Mann SA; Luchini C; Huang K; Zhang S; Sen JD; Piredda ML; Wang M; Baldrige LA; Sperling RM; Curless KL; Cheng L
Hum Pathol; 2021 Sep; 115():10-18. PubMed ID: 34052294
[TBL] [Abstract][Full Text] [Related]
2. Investigation of discrepant mismatch repair immunohistochemistry and microsatellite instability polymerase chain reaction test results for gynecologic cancers using next-generation sequencing.
Smithgall MC; Remotti H; Hsiao SJ; Mansukhani M; Liu-Jarin X; Fernandes H
Hum Pathol; 2022 Jan; 119():41-50. PubMed ID: 34666078
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Micro Satellite Instability and Mismatch Repair Status in Different Solid Tumors: A Multicenter Analysis in a Real World Setting.
Malapelle U; Parente P; Pepe F; De Luca C; Pisapia P; Sgariglia R; Nacchio M; Gragnano G; Russo G; Conticelli F; Bellevicine C; Vigliar E; Iaccarino A; Covelli C; Balistreri M; Clemente C; Perrone G; Danza A; Scaramuzzi F; Fassan M; Troncone G; Graziano P
Cells; 2021 Jul; 10(8):. PubMed ID: 34440647
[TBL] [Abstract][Full Text] [Related]
4. Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumors.
Shimozaki K; Hayashi H; Tanishima S; Horie S; Chida A; Tsugaru K; Togasaki K; Kawasaki K; Aimono E; Hirata K; Nishihara H; Kanai T; Hamamoto Y
Sci Rep; 2021 Oct; 11(1):20003. PubMed ID: 34625576
[TBL] [Abstract][Full Text] [Related]
5. ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1/PD-L1 expression and tumour mutational burden: a systematic review-based approach.
Luchini C; Bibeau F; Ligtenberg MJL; Singh N; Nottegar A; Bosse T; Miller R; Riaz N; Douillard JY; Andre F; Scarpa A
Ann Oncol; 2019 Aug; 30(8):1232-1243. PubMed ID: 31056702
[TBL] [Abstract][Full Text] [Related]
6. A retrospective study of consistency between immunohistochemistry and polymerase chain reaction of microsatellite instability in endometrial cancer.
Wang C; Kuang W; Zeng J; Ren Y; Liu Q; Sun H; Feng M; Liang D
PeerJ; 2023; 11():e15920. PubMed ID: 37663290
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of microsatellite instability by next-generation sequencing, MSI PCR and MMR immunohistochemistry in 1942 solid cancers.
Kang SY; Kim DG; Ahn S; Ha SY; Jang KT; Kim KM
Pathol Res Pract; 2022 May; 233():153874. PubMed ID: 35405622
[TBL] [Abstract][Full Text] [Related]
8. Identifying mismatch repair-deficient colon cancer: near-perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population-based series.
Loughrey MB; McGrath J; Coleman HG; Bankhead P; Maxwell P; McGready C; Bingham V; Humphries MP; Craig SG; McQuaid S; Salto-Tellez M; James JA
Histopathology; 2021 Feb; 78(3):401-413. PubMed ID: 32791559
[TBL] [Abstract][Full Text] [Related]
9. Association of Primary Resistance to Immune Checkpoint Inhibitors in Metastatic Colorectal Cancer With Misdiagnosis of Microsatellite Instability or Mismatch Repair Deficiency Status.
Cohen R; Hain E; Buhard O; Guilloux A; Bardier A; Kaci R; Bertheau P; Renaud F; Bibeau F; Fléjou JF; André T; Svrcek M; Duval A
JAMA Oncol; 2019 Apr; 5(4):551-555. PubMed ID: 30452494
[TBL] [Abstract][Full Text] [Related]
10. Performance of Next-Generation Sequencing for the Detection of Microsatellite Instability in Colorectal Cancer With Deficient DNA Mismatch Repair.
Ratovomanana T; Cohen R; Svrcek M; Renaud F; Cervera P; Siret A; Letourneur Q; Buhard O; Bourgoin P; Guillerm E; Dorard C; Nicolle R; Ayadi M; Touat M; Bielle F; Sanson M; Le Rouzic P; Buisine MP; Piessen G; Collura A; Fléjou JF; de Reyniès A; Coulet F; Ghiringhelli F; André T; Jonchère V; Duval A
Gastroenterology; 2021 Sep; 161(3):814-826.e7. PubMed ID: 33992635
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of microsatellite instability in endometroid carcinoma with deficient mismatch repair].
Zhang YH; Wu HW; Wang J; Liang ZY
Zhonghua Bing Li Xue Za Zhi; 2021 May; 50(5):470-475. PubMed ID: 33915653
[No Abstract] [Full Text] [Related]
12. A Phase II Study of Avelumab Monotherapy in Patients with Mismatch Repair-Deficient/Microsatellite Instability-High or POLE-Mutated Metastatic or Unresectable Colorectal Cancer.
Kim JH; Kim SY; Baek JY; Cha YJ; Ahn JB; Kim HS; Lee KW; Kim JW; Kim TY; Chang WJ; Park JO; Kim J; Kim JE; Hong YS; Kim YH; Kim TW
Cancer Res Treat; 2020 Oct; 52(4):1135-1144. PubMed ID: 32340084
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of microsatellite instability in endometrial cancer: The significance of minimal microsatellite shift].
Liang L; Li X; Nong L; Dong Y; Zhang JX; Li D; Li T
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Apr; 55(2):254-261. PubMed ID: 37042135
[TBL] [Abstract][Full Text] [Related]
14. Testing for Microsatellite Instability in Colorectal Cancer - a Comparative Evaluation of Immunohistochemical and Molecular Methods.
Vg DR; Nayanar SK; Gopinath V; Philip KJ; Aryadan N; Nair V; Perumal V
Gulf J Oncolog; 2022 May; 1(39):70-78. PubMed ID: 35695349
[TBL] [Abstract][Full Text] [Related]
15. Single-Agent Neoadjuvant Immunotherapy With a PD-1 Antibody in Locally Advanced Mismatch Repair-Deficient or Microsatellite Instability-High Colorectal Cancer.
Pei F; Wu J; Zhao Y; He W; Yao Q; Huang M; Huang J
Clin Colorectal Cancer; 2023 Mar; 22(1):85-91. PubMed ID: 36528470
[TBL] [Abstract][Full Text] [Related]
16. Clinical Testing for Mismatch Repair in Neoplasms Using Multiple Laboratory Methods.
Yang RK; Chen H; Roy-Chowdhuri S; Rashid A; Alvarez H; Routbort M; Patel KP; Luthra R; Medeiros LJ; Toruner GA
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230473
[TBL] [Abstract][Full Text] [Related]
17. Detection of microsatellite instability with Idylla MSI assay in colorectal and endometrial cancer.
Ukkola I; Nummela P; Pasanen A; Kero M; Lepistö A; Kytölä S; Bützow R; Ristimäki A
Virchows Arch; 2021 Sep; 479(3):471-479. PubMed ID: 33755781
[TBL] [Abstract][Full Text] [Related]
18. [Mismatch repair protein expression of colorectal cancer: a retrospective analysis of 3 428 cases].
Liu Y; Guo YH; Luo Y; Sun L; Zhao S; Shao B; Zang FL; Qiu ZQ; Sun BC; Sun Y
Zhonghua Bing Li Xue Za Zhi; 2021 Apr; 50(4):369-375. PubMed ID: 33831997
[No Abstract] [Full Text] [Related]
19. Microsatellite instability and mismatch repair protein deficiency: equal predictive markers?
Nádorvári ML; Lotz G; Kulka J; Kiss A; Tímár J
Pathol Oncol Res; 2024; 30():1611719. PubMed ID: 38655493
[TBL] [Abstract][Full Text] [Related]
20. Heterogeneity of Mismatch Repair Status and Microsatellite Instability between Primary Tumour and Metastasis and Its Implications for Immunotherapy in Colorectal Cancers.
Evrard C; Messina S; Sefrioui D; Frouin É; Auriault ML; Chautard R; Zaanan A; Jaffrelot M; De La Fouchardière C; Aparicio T; Coriat R; Godet J; Silvain C; Randrian V; Sabourin JC; Guimbaud R; Miquelestorena-Standley E; Lecomte T; Moulin V; Karayan-Tapon L; Tachon G; Tougeron D
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
